Tana, I have previously asked JC how many prospective partners are there. He responded with "There are several and a couple are also interested in the Integrase program"
I like the structure that they have put in place, it means that AVX have taken control of the due diligence process and will not allow large pharma to dictate terms. Clearly there are a number of interested parties and why wouldn't there be as Worthind has pointed out ATC has outperformed 3TC which is world best care. 3TC also comes off patent in 2011.
AVX Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held
